BHVN BHVN

Biohaven Pharmaceutical Stock Price

148.01
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
148.01
Volume 0
Bid Price
Ask Price
News -
Day High

Low
79.01

52 Week Range

High
151.51

Day Low
Company Name Stock Ticker Symbol Market Type
Biohaven Pharmaceutical Holding Company Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 148.01 20:00:00
Open Price Low Price High Price Close Price Prev Close
148.01
Trades Volume Avg Volume 52 Week Range
0 0 - 79.01 - 151.51
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 148.01 USD

Period:

Draw Mode:

Biohaven Pharmaceutical Holding Company Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.58B 71.49M 64.59M $ 462.51M $ -359.05M -13.13 -10.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 870.00 9.20%

more financials information »

Biohaven Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BHVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week147.40148.225147.13147.82384,8430.610.41%
1 Month145.95148.225145.73146.70507,4422.061.41%
3 Months143.35148.225142.65145.23791,4654.663.25%
6 Months140.39148.22579.01134.081,189,3977.625.43%
1 Year118.97151.5179.01131.37852,19329.0424.41%
3 Years39.64151.5126.5690.30752,289108.37273.39%
5 Years25.31151.5116.500174.73649,763122.70484.79%

Biohaven Pharmaceutical Description

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.


Your Recent History
NYSE
BHVN
Biohaven P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now